Skip to main content

Blog

WATCH: Capricor Data Update From Ongoing HOPE-2 Open Label Extension Trial – Webinar Recording

...

PDC Submits White Paper Supporting Accelerated Approval for AAV Gene Therapies to FDA

...

PPMD Invests $500,000 in Myosana Therapeutics to Advance Non-Viral Gene Therapy Platform

...

REGENXBIO Announces RGX-202 Gene Therapy Trial is Active & Recruiting

...

PPMD Urges FDA to Conduct a Full Review of Ataluren (Translarna)

...

Introducing PPMD Lighthouse Workshops: Let’s Navigate, Together.

...

Your Registry Data at Work: More Complete Data Betters Our Understanding of Duchenne & Becker

...

Magical Miles & $300,000 Raised with the Race to End Duchenne at Walt Disney World Marathon Weekend

...

Update from Santhera & ReveraGen: FDA Acceptance of New Drug Application for Vamorolone in Duchenne

...

Thank You for Helping Ensure Hearts Grow Stronger With Every Beat!

...